StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3029% above fair value
$515.02−5.64 (-1.08%)

Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –

Vertex Pharmaceuticals Workplace Safety by Year

Workplace Safety — Days Away, Restricted or Transferred (DART) rate (per 200,000 hours)

Vertex Pharmaceuticals Workplace Safety: 0.12 in FY2025, down 25.0% from a year earlier.

Latest, FY2025
0.12
Period ended Dec 31, 2025
Change on a year earlier
-25.0%
0.16 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Where the FY2025 figure comes from

“DART (per 200,000 hours worked)3 0.12 0.16 0.15”

Source: Vertex Corporate Responsibility / ESG Report (2025-Vertex-Data-Summary.pdf) ↗

Reported in Vertex Corporate Responsibility & Data Summary Reports.

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Vertex Pharmaceuticals Workplace Safety, annual FY2019–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/esg-dart

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?